Regal Assets Analytics

In Depth Research

Latest In-Depth Research by GeoInvesting

Purple Innovation: Do Shareholders Really Know What They Own?

By |2020-10-30T14:50:59-04:00October 30th, 2020|Categories: Consumer Goods, GeoTeam Articles, In Depth Research, Insights, Leisure Goods, Personal Goods, Value Walk|

Summary Please note, we were unable to find evidence that [...]

UP Fintech Holdings Ltd. Subsidiary Receives Anti-Money Laundering Warning in a Jurisdiction where It Books ~85% of revenue

By |2020-07-21T08:18:57-04:00July 11th, 2020|Categories: GeoTeam Articles, GeoTeam Research, In Depth Research, Insights, Spotlight Articles|Tags: , , |

Background On October 16, 2019, we published a bearish exposé on [...]

Maj Soueidan Presents Bullish Idea at Contrarian Investor Virtual Conference

By |2021-02-23T18:45:22-05:00April 20th, 2020|Categories: In Depth Research, Insights, Interviews, Maj Soueidan, Value Walk|

GeoInvesting Co-founder Maj Soueidan today presented a pitch at the [...]

Coronavirus Impact on Near-term Growth Prospects For Intouch Insight (INXSF)

By |2021-05-10T15:05:13-04:00March 26th, 2020|Categories: Education, In Depth Research, Maj Soueidan, Video Shelf|Tags: , | Intouch Insight offers a complete portfolio of customer experience [...]

Introducing New GeoInvesting Analyst Mike Woloski

By |2020-03-29T18:59:21-04:00March 25th, 2020|Categories: Education, Guest Contributors, In Depth Research, Insights, Interviews, Maj Soueidan, Video Shelf|Tags: |   As previously touched upon, Maj and [...]

Blueprint Gains Approval for Cancer Drug, Shares Climbing

By |2020-10-20T14:51:44-04:00January 10th, 2020|Categories: Bill Langbein, Health Care Equipment & Services, Healthcare, In Depth Research, SanaCurrents, SanaCurrents Updates|Tags: |

The FDA approved the lead cancer drug from Blueprint Medicines [...]

Go to Top